Results 111 to 120 of about 172,233 (314)
Extended anticoagulation after venous thromboembolism: should it be done?
Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of ...
Caio J. Fernandes +5 more
doaj +1 more source
Background Oral anticoagulation therapy has proven beneficial impact on the prevention of thromboembolic events. However, the use of antocoagulatns also increases the risk of bleeds.
Van den Bemt, Bart J. F. +12 more
core +1 more source
Outpatient Anticoagulation Management
Objectives Warfarin Management Anticoagulation Module in Epic Brief summary of Direct Oral Anticoagulants (DOACs) Brief Perioperative Anticoagulation ...
du Breuil, MD, Anne
core
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Objective To analyse the role of anticoagulation therapy in cardiopulmonary resuscitation (CPR) following an in-hospital cardiac arrest. Methods This single-centre retrospective cohort study enrolled patients treated with in-hospital CPR that met the ...
Hai Wang +6 more
doaj +1 more source
Anticoagulation in the Elderly
Management of anticoagulation in elderly patients represents a particularly challenging issue. Indeed, this patient population is at high thromboembolic risk, but also at high hemorrhagic risk. Assessment of the benefit-risk balance of anticoagulation is
Robert-Ebadi, Helia +3 more
core +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
A Modern Pharmacological Approach to Anticoagulation
This literature review examines the evolution, mechanisms, and clinical applications of anticoagulant therapies. It is focused on comparing traditional agents like warfarin and heparins with modern direct oral anticoagulants (DOACs).
Gammoh, Nasser
core
Anticoagulation and Reversal Drugs
Management of anticoagulation, is a common practice. This chapter discusses best approaches, heparin choices, and safety issues. Anticoagulation is required in immobilized patients in the neurosciences intensive care unit to prevent deep venous ...
Sarah L. Clark, Eelco F. M. Wijdicks
core +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source

